Boston Scientific Corp.

BSXNYSEUSD
49.15 USD
0.14 (0.28%)🟢PRE MARKET (AS OF 05:44 AM EDT)
🟢Market: OPEN

BSX is currently priced at $49.15. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Valuation metrics place BSX at a fair price relative to peers.

Technical & fundamental data as of Aug 24, 2026.

Open?$49.03
High?$49.26
Low?$48.96
Prev. Close?$49.01
Volume?7.0K
Avg. Volume?20.0M
VWAP?$49.10
Rel. Volume?0.00x
Bid / Ask
Bid?$49.02 × 100
Ask?$49.32 × 100
Spread?$0.30
Midpoint?$49.17
Valuation & Ratios
Market Cap?71.0B
Shares Out?1.4B
Float?1.5B
Float %?99.6%
P/E Ratio?19.33
P/B Ratio?2.85
EPS?$2.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Employees
59.0K
Market Cap
73.0B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1992-05-18
Address
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Phone: 508-683-4000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
76
Momentum?
27
Short Sent.?
80
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.18Safe
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.50%Low
Short Interest?22.3M
Days to Cover?1.0
Free Float1.5B
Avg Daily Volume22.0M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.24Adequate
Quick Ratio?0.74Weak
Cash Ratio?0.08Low
Debt/Equity?0.51Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
78/100
P/E?
Peers
73
S&P
67
19.3FAIR
P/B?
Peers
63
S&P
58
2.85CHEAP
P/S?
Peers
45
S&P
45
3.38FAIR
P/FCF?
Peers
45
S&P
57
19.6CHEAP
EV/EBITDA?
Peers
64
S&P
56
13.9FAIR
EV/Sales?
Peers
45
S&P
47
3.96FAIR
Returns & Efficiency
ROE?
Peers
75
S&P
53
14.7%STRONG
ROA?
Peers
91
S&P
66
8.1%STRONG
Cash Flow & Enterprise
FCF?$3.6B
Enterprise Value?$83.1B
Fundamentals ratios updated end of day